Depreciation of IGM Biosciences, Inc. from 31 Dec 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IGM Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2017 to 31 Mar 2025.
  • IGM Biosciences, Inc. Depreciation for the quarter ending 31 Mar 2025 was $2,272,000, a 4.4% increase year-over-year.
  • IGM Biosciences, Inc. annual Depreciation for 2024 was $9,112,000, a 10% increase from 2023.
  • IGM Biosciences, Inc. annual Depreciation for 2023 was $8,277,000, a 36% increase from 2022.
  • IGM Biosciences, Inc. annual Depreciation for 2022 was $6,075,000, a 35% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

IGM Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,272,000 +$96,000 +4.4% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $2,176,000 +$512,000 +31% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $1,664,000 +$440,000 +36% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $5,035,000 $1,224,000 +$551,000 +82% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $4,484,000 $1,311,000 +$908,000 +225% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
Q3 2021 $3,576,000 $1,100,000 +$900,000 +450% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $2,676,000 $1,400,000 +$1,200,000 +600% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,476,000 $673,000 +$451,000 +203% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $1,025,000 $403,000 +$220,000 +120% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2023 2022 FY
Q3 2020 $805,000 $200,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $805,000 $200,000 +$100,000 +100% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $705,000 $222,000 +$108,000 +95% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $597,000 $183,000 01 Oct 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY
Q3 2019 $200,000 +$100,000 +100% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $100,000 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $114,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q3 2018 $100,000 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3

IGM Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,112,000 +$835,000 +10% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $8,277,000 +$2,202,000 +36% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $6,075,000 +$1,591,000 +35% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2025 2024 FY
2021 $4,484,000 +$3,459,000 +337% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $1,025,000 +$428,000 +72% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2023 2022 FY
2019 $597,000 +$319,000 +115% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY
2018 $278,000 +$117,000 +73% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2021 2020 FY
2017 $161,000 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.